Image pharmaphorum Editor AZ-roundtable-debate-2017 Video roundtable – Part 2 Part 2 of the roundtable video debate on the challenges to secondary prevention in current clinical practice AZ-roundtable-debate-2017 Video roundtable – Part 3 Part 3 of the roundtable video debate on the opportunity for improved secondary prevention of recurrent events among high-risk patients AZ-roundtable-interviews-2017 Video interview – Professor Evangelos Giannitsis Discussion with expert cardiologist Professor Evangelos Giannitsis AZ-roundtable-interviews-2017 Video interview – Nick Hartshorne-Evans Discussion with expert patient Nick Hartshorne-Evans Load more results
AZ-roundtable-debate-2017 Video roundtable – Part 2 Part 2 of the roundtable video debate on the challenges to secondary prevention in current clinical practice
AZ-roundtable-debate-2017 Video roundtable – Part 3 Part 3 of the roundtable video debate on the opportunity for improved secondary prevention of recurrent events among high-risk patients
AZ-roundtable-interviews-2017 Video interview – Professor Evangelos Giannitsis Discussion with expert cardiologist Professor Evangelos Giannitsis
AZ-roundtable-interviews-2017 Video interview – Nick Hartshorne-Evans Discussion with expert patient Nick Hartshorne-Evans
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.